(EMAILWIRE.COM, February 13, 2019 ) Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the Human Microbiome Market.

Based on disease, the market is categorized into obesity, diabetes, autoimmune disorders, cancer, acute diarrhea, mental disorders, and other diseases such as cardiovascular diseases, other immune disorders (irritable bowel syndrome), metabolic syndrome (elevated blood lipids, high BP, and liver diseases), other mental disorders (bipolar disorders, schizophrenia, and drug metabolism), and atopic dermatitis.

Acute diarrhea is expected to account for the largest share of the market in 2022. Factors such as rising prevalence of communicable diseases, growing awareness among patients regarding the use of microbiome-based products, and technological advancements will stimulate the growth of this segment in the human microbiome disease market.

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904

The human microbiome research spending market, by technology, is divided into cell culture technology, high-throughput technology, omics technology, and computational tools. The cell culture technology is the most widely-used technology in microbiome research, and is expected to account for the largest share of the human microbiome research spending market in 2016. The large share of this segment can be attributed to its usage in the in vitro model to reproduce in vivo conditions and to study host-microbial community interactions.

Europe is expected to dominate the market with a share of in 2022. It is the prime market for microbiome companies due to the huge awareness and acceptance of microbiome-based products, rising incidences of chronic and lifestyle diseases, and high awareness of pharmacogenomics/personalized medicine in this region. In addition, major local companies have easy access to this market, which makes Europe the largest and most significant market for suppliers.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult Honsha Co., Ltd. (Japan), E. I. Du Pont de Nemours and Company (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome, Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences, Inc. (U.S.), Osel, Inc. (U.S.), and Merck & Co, Inc. (U.S.)

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37621904

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com